Security key
78397T202
SAB Biotherapeutics, Inc. - Common Stock, $0.0001 par value per share (SABS)
CUSIP: 78397T202
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 3,141,736
- Total 13F value
- $8,482,377
- Share change
- +25,373
- SEC-reported price per share
- $2.70
- Number of holders
- 24
- Value change
- +$68,507
- Number of buys
- 6
- Number of sells
- 5
- Shares outstanding
- 76,568,369
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
24
Top holders
10
SABS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2024
Previous quarter: Q2 2024
SAB Biotherapeutics, Inc. SEC filings
SAB Biotherapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 78397T202
Recent filing periods:
Ownership snapshot
Top reported holders of SABS - SAB Biotherapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BVF INC/IL
Disclosed value leader
BVF INC/IL
Comparable rows
15/15
Latest evidence
30 Jun 2024
13F
Lead comparable stake: 1.2%
Showing 1-6 of 15 holder rows.
Quick read
BVF INC/IL leads the comparable SEC ownership view at 1.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BVF INC/IL's linked filing trail.
Comparable ownership
Top 5
BVF INC/IL
1.2%
RTW INVESTMENTS, LP
1%
MARSHALL WACE, LLP
0.6%
Sessa Capital IM, L.P.
0.6%
VANGUARD GROUP INC
0.36%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BVF INC/IL |
13F
Company
|
1.2%
|
$2,845,261
917,826 shares
|
— | 30 Jun 2024 |
| RTW INVESTMENTS, LP |
13F
Company
|
1%
|
$2,377,533
766,946 shares
|
— | 30 Jun 2024 |
| MARSHALL WACE, LLP |
13F
Company
|
0.6%
|
$1,423,421
459,168 shares
|
— | 30 Jun 2024 |
| Sessa Capital IM, L.P. |
13F
Company
|
0.6%
|
$1,421,217
458,457 shares
|
— | 30 Jun 2024 |
| VANGUARD GROUP INC |
13F
Company
|
0.36%
|
$856,641
276,336 shares
|
— | 30 Jun 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.08%
|
$184,222
59,415 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
24
Shares
3,141,736
Rows available
24
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
21
Q3 2024 holders
24
Holder diff
3
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend